{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:26:26Z","timestamp":1771007186970,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T00:00:00Z","timestamp":1499472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570364"],"award-info":[{"award-number":["81570364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Planning Project of Wenzhou Science & Technology Bureau of Zhejiang Province of China","award":["Y20150032"],"award-info":[{"award-number":["Y20150032"]}]},{"name":"Science and Technology Planning Project of Wenzhou Science & Technology Bureau of Zhejiang Province of China","award":["Y20160118"],"award-info":[{"award-number":["Y20160118"]}]},{"name":"Foundation for the Program of Science and Technology Department of Zhejiang Province of China","award":["2014C33166"],"award-info":[{"award-number":["2014C33166"]}]},{"name":"Foundation for the Program of the Provincial Health Department of Zhejiang Province of China","award":["2014KYA136"],"award-info":[{"award-number":["2014KYA136"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00380-017-1019-y","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T23:55:13Z","timestamp":1499471713000},"page":"1506-1512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["High molecular weight fibroblast growth factor-2 as a promising prognostic\u00a0biomarker to predict the occurrence of heart failure in atrial fibrillation patients"],"prefix":"10.1007","volume":"32","author":[{"given":"Ling-Yue","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gao-Shu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,8]]},"reference":[{"issue":"21","key":"1019_CR1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JCJ, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, American College of Cardiology, American Heart Association Task Force on Practice Guidelines (2014) 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64(21):e1\u2013e76","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"1019_CR2","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369\u20132429","journal-title":"Eur Heart J"},{"issue":"35","key":"1019_CR3","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","volume":"34","author":"BP Krijthe","year":"2013","unstructured":"Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, Witteman JC, Stricker BH, Heeringa J (2013) Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 34(35):2746\u20132751","journal-title":"Eur Heart J"},{"issue":"8","key":"1019_CR4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ (2014) Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129(8):837\u2013847","journal-title":"Circulation"},{"issue":"9989","key":"1019_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","volume":"386","author":"RB Schnabel","year":"2015","unstructured":"Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D (2015) 50\u00a0year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 386(9989):154\u2013162","journal-title":"Lancet"},{"issue":"2","key":"1019_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","volume":"114","author":"Y Miyasaka","year":"2006","unstructured":"Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114(2):119\u2013125","journal-title":"Circulation"},{"issue":"1","key":"1019_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/europace\/euv191","volume":"18","author":"GY Lip","year":"2016","unstructured":"Lip GY, Heinzel FR, Gaita F, Juanatey JR, Le Heuzey JY, Potpara T, Svendsen JH, Vos MA, Anker SD, Coats AJ, Haverkamp W, Manolis AS, Chung MK, Sanders P, Pieske B, Gorenek B, Lane D, Boriani G, Linde C, Hindricks G, Tsutsui H, Homma S, Brownstein S, Nielsen JC, Lainscak M, Crespo-Leiro M, Piepoli M, Seferovic P, Savelieva I, EP-Europace (2016) European Heart Rhythm Association Heart Failure Association joint consensus document on arrhythmias in heart failure. Europace 18(1):12\u201336","journal-title":"Europace"},{"issue":"3","key":"1019_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrcardio.2015.191","volume":"13","author":"LH Ling","year":"2016","unstructured":"Ling LH, Kistler PM, Kalman JM, Schilling RJ, Hunter RJ (2016) Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol 13(3):131\u2013147","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"1019_CR9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cardiores.2004.04.024","volume":"63","author":"E Kardami","year":"2004","unstructured":"Kardami E, Jiang ZS, Jimenez SK, Hirst CJ, Sheikh F, Zahradka P, Cattini PA (2004) Fibroblast growth factor 2 isoforms and cardiac hypertrophy. Cardiovasc Res 63(3):458\u2013466","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1019_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0008-6363(02)00708-3","volume":"57","author":"KA Detillieux","year":"2003","unstructured":"Detillieux KA, Sheikh F, Kardami E, Cattini PA (2003) Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 57(1):8\u201319","journal-title":"Cardiovasc Res"},{"issue":"5","key":"1019_CR11","doi-asserted-by":"crossref","first-page":"e97281","DOI":"10.1371\/journal.pone.0097281","volume":"9","author":"JJ Santiago","year":"2014","unstructured":"Santiago JJ, McNaughton LJ, Koleini N, Ma X, Bestvater B, Nickel BE, Fandrich RR, Wigle JT, Freed DH, Arora RC, Kardami E (2014) High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling. PLoS One 9(5):e97281","journal-title":"PLoS One"},{"key":"1019_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12967-015-0510-4","volume":"13","author":"DA Svystonyuk","year":"2015","unstructured":"Svystonyuk DA, Ngu JM, Mewhort HE, Lipon BD, Teng G, Guzzardi DG, Malik G, Belke DD, Fedak PW (2015) Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling. J Transl Med 13:147","journal-title":"J Transl Med"},{"key":"1019_CR13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.biomaterials.2015.08.050","volume":"72","author":"WC Chen","year":"2015","unstructured":"Chen WC, Lee BG, Park DW, Kim K, Chu H, Kim K, Huard J, Wang Y (2015) Controlled dual delivery of fibroblast growth factor-2 and interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair. Biomaterials 72:138\u2013151","journal-title":"Biomaterials"},{"issue":"8","key":"1019_CR14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","volume":"66","author":"MS Dzeshka","year":"2015","unstructured":"Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E (2015) Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol 66(8):943\u2013959","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"1019_CR15","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787\u20131847","journal-title":"Eur Heart J"},{"issue":"16","key":"1019_CR16","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62(16):e147\u2013e239","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1019_CR17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","volume":"51","author":"B Burstein","year":"2008","unstructured":"Burstein B, Nattel S (2008) Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51(8):802\u2013809","journal-title":"J Am Coll Cardiol"},{"key":"1019_CR18","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1083\/jcb.109.4.1865","volume":"109","author":"E Kardami","year":"1989","unstructured":"Kardami E, Fandrich RR (1989) Basic fibroblast growth factor in atria and ventricles of the vertebrate heart. J Cell Biol 109:1865\u20131875","journal-title":"J Cell Biol"},{"issue":"5","key":"1019_CR19","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1097\/CCM.0000000000000226","volume":"42","author":"H Zhang","year":"2014","unstructured":"Zhang H, Wang T, Zhang K, Liu Y, Huang F, Zhu X, Liu Y, Wang MH, Tang W, Wang J, Huang H (2014) Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2. Crit Care Med 42(5):e345\u2013e354","journal-title":"Crit Care Med"},{"issue":"5","key":"1019_CR20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3892\/etm.2013.1274","volume":"6","author":"M Li","year":"2013","unstructured":"Li M, Yi X, Ma L, Zhou Y (2013) Hepatocyte growth factor and basic fibroblast growth factor regulate atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease via the mitogen-activated protein kinase signaling pathway. Exp Ther Med 6(5):1121\u20131126","journal-title":"Exp Ther Med"},{"issue":"5","key":"1019_CR21","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2353\/ajpath.2007.070003","volume":"171","author":"JA Virag","year":"2007","unstructured":"Virag JA, Rolle ML, Reece J, Hardouin S, Feigl EO, Murry CE (2007) Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. Am J Pathol 171(5):1431\u20131440","journal-title":"Am J Pathol"},{"issue":"23","key":"1019_CR22","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","volume":"107","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D\u2019Agostino RB, Murabito JM, Kannel WB, Benjamin EJ (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107(23):2920\u20132925","journal-title":"Circulation"},{"issue":"12","key":"1019_CR23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","volume":"63","author":"AP Ambrosy","year":"2014","unstructured":"Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CS, Sato N, Shah AN, Gheorghiade M (2014) The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63(12):1123\u20131133","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1019_CR24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Dahlstrom U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L, Heart Failure Association of the European Society of Cardiology (HFA) (2013) EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 15(7):808\u2013817","journal-title":"Eur J Heart Fail"},{"issue":"9665","key":"1019_CR25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","volume":"373","author":"RB Schnabel","year":"2009","unstructured":"Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D\u2019Agostino RB, Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ (2009) Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 373(9665):739\u2013745","journal-title":"Lancet"},{"issue":"23","key":"1019_CR26","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/eurheartj\/ehl359","volume":"27","author":"OD Pedersen","year":"2006","unstructured":"Pedersen OD, S\u00f8ndergaard P, Nielsen T, Nielsen SJ, Nielsen ES, Falstie-Jensen N, Nielsen I, K\u00f8ber L, Burchardt H, Seibaek M, Torp-Pedersen C (2006) Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. Eur Heart J 27(23):2866\u20132870","journal-title":"Eur Heart J"},{"issue":"10","key":"1019_CR27","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","volume":"47","author":"LG Olsson","year":"2006","unstructured":"Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA, CHARM Investigators (2006) Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 47(10):1997\u20132004","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-017-1019-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-017-1019-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-017-1019-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T16:42:54Z","timestamp":1509554574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-017-1019-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,8]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1019"],"URL":"https:\/\/doi.org\/10.1007\/s00380-017-1019-y","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,8]]}}}